Table 2.
General characteristics of patients with ICVD with the highest and lowest tertiles of CCAB.
| Characteristics | Total (n = 40) | Highest tertile (n = 14) | Lowest tertile (n = 14) | Statistical values | P |
|---|---|---|---|---|---|
| Age (years) | 62 ± 8 | 67 ± 6 | 60 ± 7 | −2.983a | 0.006d |
| Male | 33 (82.5) | 12 (85.7) | 12 (85.7) | 0.000b | 1.000 |
| Hypertension history | 31 (77.5) | 13 (92.9) | 9 (64.3) | 3.642b | 0.056 |
| Diabetes mellitus history | 18 (45.0) | 6 (42.9) | 5 (35.7) | 0.150b | 0.699 |
| Hyperlipidemia history | 33 (82.5) | 13 (92.9) | 10 (71.4) | 2.320b | 0.128 |
| Coronary artery disease history | 18 (45.0) | 9 (64.3) | 6 (42.9) | 1.292b | 0.256 |
| Current smoking | 14 (35.0) | 6 (42.9) | 6 (42.9) | 0.000b | 1.000 |
| Overweight | 22 (55.0) | 10 (71.4) | 5 (35.7) | 3.590b | 0.058 |
| Onset of ICVD within 14 days | 20 (50.0) | 7 (50.0) | 7 (50.0) | 0.000b | 1.000 |
| Dual antiplatelet therapy | 21 (52.5) | 7 (50.0) | 6 (42.9) | 0.144b | 0.705 |
| SBP at admission (mmHg) | 144.1 ± 24.2 | 143.9 ± 31.5 | 144.4 ± 23.8 | 0.047a | 0.963 |
| DBP at admission (mmHg) | 83.6 ± 14.9 | 80.1 ± 15.9 | 86.7 ± 16.1 | 1.098a | 0.282 |
| Leukocyte number (109/L) | 6.97 ± 2.18 | 6.11 ± 1.63 | 7.59 ± 2.73 | 1.746a | 0.093 |
| Platelet number (109/L) | 207 (176, 227) | 202 (171, 226) | 210 (168, 225) | −0.276c | 0.783 |
| Fasting glucose (mg/dL) | 5.12 (4.56, 6.52) | 5.35 (4.64, 6.64) | 4.72 (4.42, 7.35) | −0.388c | 0.698 |
| LDL-C (mmol/L) | 1.87 (1.62, 2.37) | 1.81 (1.43, 2.32) | 2.11 (1.74, 2.96) | −1.335c | 0.182 |
| Fibrinogen (g/L) | 3.43 ± 0.76 | 3.25 ± 0.52 | 3.61 ± 1.03 | 1.098a | 0.249 |
| D-dimer (mg/L) | 0.28 (0.17, 0.45) | 0.30 (0.20, 0.58) | 0.27 (0.14, 0.38) | −1.093c | 0.274 |
| hsCRP (mg/L) | 1.15 (0.42, 2.79) | 0.90 (0.41, 1.61) | 1.43 (0.37, 5.13) | −0.688c | 0.491 |
Data were shown as mean ± SD, median (Q1, Q3), or n (%).
ICVD; ischemic cerebrovascular disease; CCAB; cardio-cerebral atherosclerosis burden; SBP; systolic blood pressure; DBP; diastolic blood pressure; LDL-C; low-density lipoprotein cholesterol; hsCRP; hypersensitive C-reactive protein.
a
t values.
b
Chi-square value.
c
Z value.
d
A P-value <0.05 was considered statistically significant.